Your browser doesn't support javascript.
loading
Targeting RLIP with CRISPR/Cas9 controls tumor growth.
Singhal, Jyotsana; Chikara, Shireen; Horne, David; Awasthi, Sanjay; Salgia, Ravi; Singhal, Sharad S.
Afiliação
  • Singhal J; Department of Medical Oncology, City of Hope Comprehensive Cancer Center and National Medical Center, Duarte, CA, USA.
  • Chikara S; Department of Molecular Medicine, City of Hope Comprehensive Cancer Center and National Medical Center, Duarte, CA, USA.
  • Horne D; Department of Medical Oncology, City of Hope Comprehensive Cancer Center and National Medical Center, Duarte, CA, USA.
  • Awasthi S; Department of Molecular Medicine, City of Hope Comprehensive Cancer Center and National Medical Center, Duarte, CA, USA.
  • Salgia R; Department of Internal Medicine, Texas Tech University Health Sciences Center, Lubbock, TX, USA.
  • Singhal SS; Department of Medical Oncology, City of Hope Comprehensive Cancer Center and National Medical Center, Duarte, CA, USA.
Carcinogenesis ; 42(1): 48-57, 2021 02 11.
Article em En | MEDLINE | ID: mdl-32426802

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Neoplasias da Mama / Terapia Genética / Transportadores de Cassetes de Ligação de ATP / Proteínas Ativadoras de GTPase / Sistemas CRISPR-Cas Limite: Female / Humans Idioma: En Ano de publicação: 2021 Tipo de documento: Article

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Neoplasias da Mama / Terapia Genética / Transportadores de Cassetes de Ligação de ATP / Proteínas Ativadoras de GTPase / Sistemas CRISPR-Cas Limite: Female / Humans Idioma: En Ano de publicação: 2021 Tipo de documento: Article